
1. General Information
Bosutris 500 mg Tablet contains Bosutinib 500 mg and belongs to a class of medicines called tyrosine kinase inhibitors (TKIs). It is an oral prescription anti-cancer medicine primarily used in the treatment of certain forms of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
Bosutinib works by targeting abnormal proteins involved in the growth and multiplication of leukemia cells. It is generally prescribed by an oncologist or hematologist following evaluation of the patient's condition and previous treatment history.
Exporter: Phoenix Exim
Location: Nagpur, India
Product: Bosutris 500 mg Tablet
Active ingredient: Bosutinib 500 mg
Dosage form: Film-coated oral tablet
Therapeutic category: Antineoplastic / Tyrosine Kinase Inhibitor
Prescription status: Prescription medicine
2. Product Information
Bosutris 500 mg Tablet is formulated with bosutinib 500 mg. It is supplied as an oral tablet and should be used only according to the treatment plan prescribed by a qualified healthcare professional.
Bosutinib is a kinase inhibitor that acts against abnormal signaling proteins associated with certain leukemia cells. The medicine requires appropriate medical monitoring during treatment, including laboratory assessment as directed by the treating physician.
3. Uses of Bosutris 500 mg
Bosutris 500 mg is primarily used for:
- Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
- Certain patients with chronic, accelerated, or blast-phase CML, depending on their treatment history and physician's assessment.
- It may be prescribed when previous treatment has been ineffective or not tolerated, depending on the approved indication and patient's clinical circumstances.
Bosutinib should not be used for cancer treatment without a specialist's diagnosis and prescription.
4. Benefits of Bosutris 500 mg
The potential therapeutic benefits of bosutinib include:
- Helps inhibit abnormal signaling responsible for leukemia-cell growth.
- Helps slow the multiplication of certain cancer cells.
- Can help control Ph+ CML in appropriately selected patients.
- Provides an oral targeted-treatment option for eligible patients.
- May be useful for patients whose previous CML treatment was unsuccessful or not tolerated, when bosutinib is considered appropriate by the treating specialist.
The response to treatment varies between patients and should be assessed through clinical evaluation and appropriate laboratory testing.
5. Side Effects of Bosutris 500 mg
Like other anti-cancer medicines, Bosutris may cause side effects. Possible adverse effects include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Fatigue
- Rash
- Decreased platelet count
- Decreased white blood cell count
- Anemia
- Increased liver enzymes
- Cough
- Respiratory tract infections
- Breathlessness
- Loss of appetite
- Dizziness
Some adverse effects can be serious. Patients should contact their healthcare professional if they develop severe or persistent symptoms.
6. Common Side Effects
Frequently reported side effects include:
- Diarrhea
- Nausea
- Vomiting
- Abdominal pain
- Headache
- Fatigue
- Rash
- Reduced platelet count
- Anemia
- Reduced white blood cell count
- Increased liver enzymes
- Cough
- Respiratory tract infection
- Breathlessness
Diarrhea and gastrointestinal symptoms are particularly important to monitor. Persistent or severe diarrhea should be reported to the treating doctor.
7. How to Use Bosutris 500 mg
Bosutris 500 mg should be taken only according to the dose and schedule prescribed by the treating physician.
General administration guidance includes:
- Take the tablet as directed by your doctor.
- Swallow the tablet whole with water.
- Do not crush, chew or break the tablet unless specifically instructed by a healthcare professional.
- Take it consistently at the prescribed time.
- Follow your oncologist's instructions regarding whether and how it should be taken with food.
- Do not stop treatment or change the dose without consulting your doctor.
- If you miss a dose, follow the missed-dose instructions provided by your healthcare professional rather than taking an extra dose.
The exact dose and duration depend on the patient's diagnosis, treatment history, tolerability and other medical factors.
8. How Bosutris 500 mg Works
Bosutris contains bosutinib, a tyrosine kinase inhibitor.
In Ph+ CML, abnormal signaling involving BCR-ABL contributes to uncontrolled growth of leukemia cells. Bosutinib inhibits kinase activity involved in this abnormal signaling pathway, helping reduce the growth and multiplication of leukemia cells.
In simple terms, Bosutris helps block abnormal signals that tell certain leukemia cells to keep growing.
9. Safety Advice
Bosutris 500 mg is a specialist prescription medicine and requires appropriate medical supervision.
Pregnancy
Bosutinib can cause harm to a developing fetus. Women who are pregnant or planning pregnancy should discuss treatment with their doctor before taking it. Appropriate contraception should be discussed with the treating healthcare professional.
Breastfeeding
Breastfeeding should be discussed with the treating physician because bosutinib may pose a risk to a breastfed infant.
Liver problems
Tell your doctor about existing liver disease. Liver function may need to be monitored during treatment because bosutinib can affect liver enzymes and liver function.
Kidney problems
Patients with kidney impairment should inform their doctor because dose adjustment may be necessary.
Blood counts
Bosutinib may reduce blood-cell counts, including platelets and white blood cells. Your doctor may therefore recommend regular blood tests.
Drug interactions
Bosutinib can interact with various medicines, including certain CYP3A inhibitors and inducers. Patients should provide their doctor with a complete list of prescription medicines, over-the-counter medicines and supplements.
Grapefruit
Grapefruit and grapefruit juice may increase bosutinib exposure and should generally be avoided unless the treating physician advises otherwise.
Children
Safety and efficacy have not been established for routine use in children, so pediatric use requires specialist assessment.
10. Frequently Asked Questions
Q1. What is Bosutris 500 mg?
Bosutris 500 mg is an oral anti-cancer medicine containing bosutinib 500 mg.
Q2. What is Bosutris 500 mg used for?
It is primarily used for appropriate patients with Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML).
Q3. Is Bosutris 500 mg a chemotherapy medicine?
It is an oral targeted anti-cancer medicine classified as a tyrosine kinase inhibitor rather than conventional cytotoxic chemotherapy.
Q4. How does Bosutris work?
It inhibits abnormal kinase signaling involved in the growth and multiplication of certain leukemia cells.
Q5. Can I take Bosutris without a prescription?
No. Bosutris is a prescription anti-cancer medicine and should be used under specialist medical supervision.
Q6. What are the common side effects?
Diarrhea, nausea, vomiting, abdominal pain, headache, fatigue, rash, blood-count abnormalities and increased liver enzymes are among the reported side effects.
Q7. Can Bosutris cause diarrhea?
Yes. Diarrhea is a commonly reported adverse effect. Persistent or severe diarrhea should be reported to your doctor.
Q8. Can Bosutris affect the liver?
Yes. Bosutinib may increase liver enzymes and can cause liver toxicity, so medical monitoring may be required.
Q9. Can pregnant women take Bosutris?
Bosutinib can harm a developing fetus and should not be used during pregnancy unless specifically determined appropriate by the treating specialist.
Q10. Can Bosutris be taken with grapefruit juice?
Grapefruit and grapefruit juice can increase bosutinib exposure, so they should generally be avoided during treatment.
Q11. Can I stop Bosutris when I feel better?
No. Cancer treatment should not be stopped or changed without the treating oncologist's instruction.
Q12. Does Bosutris require regular medical monitoring?
Yes. Depending on the patient's circumstances, doctors may monitor blood counts, liver function and other relevant clinical parameters.
11. Substitutes for Bosutris 500 mg
The appropriate substitute depends on the patient's diagnosis, treatment history, tolerance, country-specific approval and physician's decision.
Possible bosutinib-containing alternatives may include products marketed under different brand names or generic versions of bosutinib. Other CML medicines, such as imatinib, dasatinib or nilotinib, are not direct substitutes because they contain different active ingredients and have different prescribing considerations.
Therefore, patients should not switch from Bosutris to another medicine based solely on brand name or price. A hematologist/oncologist should select the appropriate alternative.
12. SEO Keywords for Phoenix Exim
Product Keywords
- Bosutris 500 mg Tablet
- Bosutris 500 mg Tablet supplier
- Bosutris 500 mg Tablet exporter
- Bosutris 500 mg Tablet manufacturer
- Bosutinib 500 mg Tablet
- Bosutinib 500 mg supplier India
- Bosutinib 500 mg exporter India
- Bosutinib 500 mg pharmaceutical supplier
- Bosutinib 500 mg medicine exporter
- Bosutinib 500 mg wholesale supplier
B2B & Export Keywords
- Bosutris 500 mg Tablet exporter from India
- Bosutinib 500 mg pharmaceutical exporter from Nagpur
- Bosutris 500 mg international medicine supplier
- Bosutinib 500 mg bulk pharmaceutical supplier
- Bosutinib 500 mg B2B supplier India
- Bosutris 500 mg wholesale pharmaceutical supplier
- Bosutinib 500 mg export supplier India
- CML medicine exporter from India
- oncology medicine exporter from Nagpur India
- anti cancer medicine supplier India
Country-Focused Keywords
- Bosutris 500 mg supplier to USA
- Bosutris 500 mg exporter to UK
- Bosutris 500 mg supplier to Australia
- Bosutris 500 mg exporter to Singapore
- Bosutris 500 mg supplier to Canada
- Bosutris 500 mg exporter to South Korea
- Bosutris 500 mg supplier to UAE
- Bosutinib 500 mg exporter from India to USA
- Bosutinib 500 mg exporter from India to UK
- Bosutinib 500 mg international pharmaceutical supplier
Long-Tail SEO Keywords
- Buy Bosutris 500 mg Tablet from pharmaceutical exporter in India
- Bosutinib 500 mg Tablet wholesale supplier from Nagpur India
- Bosutris 500 mg CML medicine supplier from India
- Bosutinib 500 mg oncology medicine exporter from Nagpur
- Trusted pharmaceutical exporter for Bosutinib 500 mg from India
- Bosutris 500 mg international B2B medicine supplier
- Bosutinib 500 mg pharmaceutical export company India
- Bosutris 500 mg medicine supplier for international markets
- Phoenix Exim Bosutris 500 mg pharmaceutical supplier
- Phoenix Exim Bosutinib 500 mg exporter from Nagpur India
Keywords







